Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. Markets closed

S&P 500
5,969.34
+20.63(+0.35%)
Dow 30
44,296.51
+426.16(+0.97%)
Nasdaq
19,003.65
+31.23(+0.16%)
Russell 2000
2,406.67
+42.65(+1.80%)
Crude Oil
71.18
+1.08(+1.54%)
Gold
2,718.20
+43.30(+1.62%)

Catalyst Pharmaceuticals, Inc. (CPRX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Follow

Visitors trend2W10W9M

21.48

+0.36

(+1.70%)

At close: 04:00PM EST

21.10

-0.38

(-1.77%)

After hours:

07:54PM EST

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	2.56B
Enterprise Value	2.12B
Trailing P/E	18.20
Forward P/E	10.80
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	5.68
Price/Book (mrq)	3.88
Enterprise Value/Revenue	4.61
Enterprise Value/EBITDA	10.04

Trading Information

Stock Price History

Beta (5Y Monthly)	0.75
52-Week Change ³	N/A
S&P500 52-Week Change ³	N/A
52 Week High ³	24.27
52 Week Low ³	13.00
50-Day Moving Average ³	21.13
200-Day Moving Average ³	17.61

Share Statistics

Avg Vol (3 month) ³	943.76k
Avg Vol (10 day) ³	1.17M
Shares Outstanding ⁵	119.27M
Implied Shares Outstanding ⁶	N/A
Float ⁸	103.02M
% Held by Insiders ¹	5.98%
% Held by Institutions ¹	81.72%
Shares Short (Oct 31, 2024) ⁴	6.01M
Short Ratio (Oct 31, 2024) ⁴	8.2
Short % of Float (Oct 31, 2024) ⁴	6.25%
Short % of Shares Outstanding (Oct 31, 2024) ⁴	5.04%
Shares Short (prior month Sep 30, 2024) ⁴	5.75M

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	N/A
Last Split Date ³	N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Sep 30, 2024

Profitability

Profit Margin	31.01%
Operating Margin (ttm)	39.56%

Management Effectiveness

Return on Assets (ttm)	18.35%
Return on Equity (ttm)	28.29%

Income Statement

Revenue (ttm)	460.48M
Revenue Per Share (ttm)	4.00
Quarterly Revenue Growth (yoy)	25.30%
Gross Profit (ttm)	N/A
EBITDA	211.43M
Net Income Avi to Common (ttm)	142.8M
Diluted EPS (ttm)	1.20
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	442.33M
Total Cash Per Share (mrq)	3.71
Total Debt (mrq)	3.28M
Total Debt/Equity (mrq)	0.50
Current Ratio (mrq)	5.11
Book Value Per Share (mrq)	5.54

Cash Flow Statement

Operating Cash Flow (ttm)	224.58M
Levered Free Cash Flow (ttm)	150.67M